IR@PKUHSC  > 北京大学临床肿瘤学院  > 超声科
学科主题临床医学
Radiofrequency ablation of hepatocellular carcinoma: Long-term outcome and prognostic factors
Yan, Kun1; Chen, Min Hua1; Yang, Wei1; Wang, Yan Bin1; Gao, Wen1; Hao, Chun Yi1; Xing, Bao Cai2; Huang, Xin Fu2
关键词Hepatocellular Carcinoma Radiofrequency Ablation Long-term Outcome Ultrasonography
刊名EUROPEAN JOURNAL OF RADIOLOGY
2008-08-01
DOI10.1016/j.ejrad.2007.07.007
67期:2页:336-347
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Radiology, Nuclear Medicine & Medical Imaging
研究领域[WOS]Radiology, Nuclear Medicine & Medical Imaging
关键词[WOS]TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION ; FOCAL LIVER-TUMORS ; THERMAL ABLATION ; HEPATIC-TUMORS ; THERAPEUTIC-EFFICACY ; UNITED-STATES ; CIRRHOSIS ; RESECTION ; SURVIVAL ; MALIGNANCIES
英文摘要

Purpose: To investigate the efficacy of radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC), and the prognostic factors for post-RFA survival rate.

Methods: From 1999 to 2006, 266 patients with 392 HCCs underwent ultrasound guided RFA treatment. They were 216 males and 50 females, average age 59.4 +/- 15.4 years (24-87 years). The HCC were 1.2-6.7 cm in diameters (average 3.9 + 1.3 cm). There were 158 patients with single tumor, and the rest had multiple (2-5) tumors. Univariate and multivariate analysis with 19 potential variables were examined to identify prognostic factors for post-RFA survival rate.

Results: The overall post-RFA survival rates at 1st, 3rd, and 5th year were 82.9%, 57.9% and 42.9%, respectively. In the 60 patients with stage I HCC (AJCC staging), the 1-, 3-, 5-year survival rate were 94.8%, 76.4% and 71.6%, significantly higher than the 148 patients with stage II-IV tumors (81.8%, 57.6% and 41.2%, P=0.006). For the 58 patients with post-surgery recurrent HCC, the survival rates were 73.2%, 41.9% and 38.2% at the 1st, 3rd, and 5th year, which were significantly lower than those of stage I HCC (P=0.005). Nine potential factors were found with significant effects on survival rate, and they were number of tumors, location of tumors, pre-RFA liver function enzymes, Child-Pugh classification, AJCC staging, primary or recurrent HCC, tumor pathological grading, using mathematical protocol in RFA procedure and tumor necrosis 1 month after RFA. After multivariate analysis, three factors were identified as independent prognostic factors for survival rate, and they were Child-Pugh classification, AJCC staging and using mathematical protocol.

Conclusion: Identifying prognostic factors provides important information for HCC patient management before, during and after RFA. This long-term follow-up study on a large group of HCC patients confirmed that RFA could not only achieve favorable outcome on stage I HCC, but also be an effective therapy for stage II-IV or recurrent HCC. (C) 2007 Elsevier Ireland Ltd. All rights reserved.

语种英语
WOS记录号WOS:000258369800019
引用统计
被引频次:56[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/52292
专题北京大学临床肿瘤学院_超声科
作者单位1.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Ultrasound, Beijing 100036, Peoples R China
2.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Surg, Beijing 100036, Peoples R China
推荐引用方式
GB/T 7714
Yan, Kun,Chen, Min Hua,Yang, Wei,et al. Radiofrequency ablation of hepatocellular carcinoma: Long-term outcome and prognostic factors[J]. EUROPEAN JOURNAL OF RADIOLOGY,2008,67(2):336-347.
APA Yan, Kun.,Chen, Min Hua.,Yang, Wei.,Wang, Yan Bin.,Gao, Wen.,...&Huang, Xin Fu.(2008).Radiofrequency ablation of hepatocellular carcinoma: Long-term outcome and prognostic factors.EUROPEAN JOURNAL OF RADIOLOGY,67(2),336-347.
MLA Yan, Kun,et al."Radiofrequency ablation of hepatocellular carcinoma: Long-term outcome and prognostic factors".EUROPEAN JOURNAL OF RADIOLOGY 67.2(2008):336-347.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yan, Kun]的文章
[Chen, Min Hua]的文章
[Yang, Wei]的文章
百度学术
百度学术中相似的文章
[Yan, Kun]的文章
[Chen, Min Hua]的文章
[Yang, Wei]的文章
必应学术
必应学术中相似的文章
[Yan, Kun]的文章
[Chen, Min Hua]的文章
[Yang, Wei]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。